𝔖 Bobbio Scriptorium

✦ LIBER ✦

Continuous combined hormone replacement therapy with 1 mg 17β-oestradiol and 5 mg dydrogesterone (Femoston®-conti): Endometrial safety and bleeding profile

✍ Scribed by C. Quereux; B. Pornel; C. Bergeron; A. Ferenczy

Book ID: 116731378
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 101 KB
Volume: 53
Category: Article
ISSN: 0378-5122
DOI: 10.1016/j.maturitas.2005.05.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ultra low dose continuous combined hormo

Ultra low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone: Protection of the endometrium and amenorrhoea rate

✍ C. Bergeron; F.F. Nogales; T. Rechberger; T. Tatarchjuk; L. Zipfel 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 279 KB

Endometrial safety of continuous combine

Endometrial safety of continuous combined hormone replacement therapy with 17β-oestradiol (1 or 2 mg) and dydrogesterone

✍ C. Bergeron; A. Ferenczy 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 108 KB

Oral ultra-low dose continuous combined

Oral ultra-low dose continuous combined hormone replacement therapy with 0.5 mg 17β-oestradiol and 2.5 mg dydrogesterone for the treatment of vasomotor symptoms: Results from a double-blind, controlled study

✍ John C. Stevenson; Gemma Durand; Elke Kahler; Tomasz Pertyński 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 383 KB